Overview of Lasilix Faible

Quick Facts

Property	Description
Active Ingredient	Furosemide (INN)
Form	Tablet (Oral solid dosage form)
Pharmacological Class	Loop Diuretic
General Purpose	To eliminate excess fluid and salt
Origin	Synthetic (Anthranilic acid derivative)

What Pharmacological Class Does Lasilix Faible Belong To?

Lasilix Faible is a prescription medication whose active ingredient is furosemide, and it is formally classified as a loop diuretic. The compound is a synthetic drug that is chemically related to the anthranilic acid and sulfonamide classes. Furosemide's classification as a loop diuretic is defined by its specific mechanism for promoting salt and water excretion. This pharmacological class is essential for defining the medicine's potential to manage substantial fluid imbalances.

Lasilix Faible: Understanding the Form and Composition

This medicine is supplied as an oral solid dosage form, specifically a tablet intended for oral administration. The distinctive aspect of this product is its name: Faible (French for 'weak' or 'low') indicates that this is a lower-strength variation of the standard furosemide formulation, differentiating it from higher-dose products. Lasilix Faible is a single-product preparation, meaning its therapeutic effect is attributed solely to the furosemide compound contained within its excipient base, making it suitable for initiation of therapy or for patients requiring a conservative approach to fluid management, such as geriatric groups.

What Is the General Purpose of a Furosemide Diuretic?

As a loop diuretic, the medicine's general purpose is to assist the body in efficiently eliminating excessive accumulations of fluid and salt. This therapeutic action is achieved by interfering with the kidneys' ability to reclaim salts from the urinary filtrate. By promoting the loss of water and sodium, the drug’s action provides relief from physical edema (fluid retention in tissues) and contributes to the overall reduction in circulating blood volume.

What side effects are possible with Lasilix Faible?

Possible Side Effects and Safety Information

This section describes the adverse reactions and safety characteristics of furosemide (the active ingredient in Lasilix Faible) as documented in official government regulatory documents.

Adverse Reaction Scope and Frequency

The most commonly documented adverse reactions are linked to the drug's primary action as a loop diuretic, leading to Fluid, Electrolyte, and Metabolic Abnormalities.

Classification	Examples of Officially Documented Reactions
Very Common	Electrolyte disturbances, dehydration, hypovolemia, increased blood creatinine.
Common	Hypomagnesemia, hyperuricemia, orthostatic hypotension.
Uncommon	Thrombocytopenia, deafness (ototoxicity), visual disturbance, nausea.
Rare/Very Rare	Agranulocytosis, aplastic anemia, severe skin reactions (e.g., SJS, TEN), vasculitis.

Adverse effects are also categorized across several System-Organ Classes (SOCs), including the Blood and Lymphatic System, Gastrointestinal System, and Ear and Labyrinth Disorders (ototoxicity).

Serious Adverse Reactions

Regulatory sources explicitly list potential serious safety events. These include Circulatory collapse or Vascular thrombosis resulting from severe volume depletion, irreversible hearing impairment, and severe anaphylactic reactions. Precipitation of Hepatic encephalopathy is a documented risk in patients with pre-existing hepatic disease.

Population-Specific Safety Notes

The official labeling defines specific safety considerations for certain patient groups. Older adults are noted to have a greater documented risk of dehydration and circulatory collapse. Patients with severe progressive renal disease or hepatic impairment require particular observation due to increased risks of azotemia and hepatic coma, respectively. Anuria (inability to produce urine) is listed as a contraindication.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation defines an overdose of Lasilix Faible (Furosemide) as a critical exaggeration of its intended effects, primarily manifesting as a state of severe volume depletion and profound hypotension (low blood pressure).

Official Overdose Manifestations	Severe Outcomes and Complications
Symptoms of excessive fluid loss include severe dehydration, lethargy, weakness, and confusion, potentially leading to loss of consciousness.	Documented severe outcomes include circulatory collapse, shock, and risk of vascular thrombosis and embolism, especially noted in elderly patients.
Key physiological findings include critical electrolyte imbalance, specifically Hypokalemia and Hyponatremia.	High-dose exposure is associated with the potential for irreversible hearing loss; patients with hepatic impairment risk precipitating hepatic encephalopathy.

Emergency Action and Supportive Management

Immediate medical attention must be sought for any signs of severe volume loss, profound weakness, or suspected circulatory compromise. The official regulatory approach for overdose is defined as symptomatic and supportive; no specific antidote is known to be available. Management requires frequent monitoring of key physiological parameters, including the patient's blood pressure and serum electrolytes. Furthermore, for patients with existing urinary retention issues, assurance of adequate drainage is required during management.

Therapeutic Uses of Lasilix Faible

What Lasilix Faible Treats: Main Uses and Benefits

Lasilix Faible is primarily applied across domains where additional symptomatic support is needed to manage symptoms related to systemic imbalance, particularly symptoms related to fluid accumulation. The medication is considered relevant for addressing symptoms linked to organ-specific functional stress, such as high blood pressure (hypertension), and conditions involving systemic or localized discomfort.

The core benefit supports the patient during difficult episodes by providing relief that helps ease the overall symptom burden, especially during conditions characterized by periods of heightened symptoms where physiological strain is noticeable. This approach contributes to improved comfort and helps maintain a sense of stability when symptoms are more noticeable.

“Support is provided to assist patients during difficult symptomatic episodes by easing distress.”

The medication is commonly used when symptoms intensify and supportive relief is needed in conditions involving episodic or fluctuating manifestations of fluid-related or cardiovascular stress.

Quick Fact: Support for Symptoms of Swelling
The product is used for managing symptoms that create noticeable physiological strain, particularly discomfort caused by swelling and physical discomfort.

Eligibility and Restrictions for Use

Lasilix Faible (furosemide 20 mg) is a potent diuretic primarily used in adults and children for treating fluid retention associated with cardiac, renal, or hepatic disease.

Contraindicated Populations

Use is strictly prohibited (contraindicated) for patients with anuria (inability to pass urine) or renal failure not responsive to furosemide, severe dehydration or hypovolemia, severe depletion of electrolytes (hypokalemia, hyponatremia), or a state of pre-coma/coma due to hepatic encephalopathy. It is also contraindicated for those with known hypersensitivity to furosemide or sulfonamide derivatives.

Special Considerations and Restrictions

Use is not recommended for breast-feeding women due to excretion into breast milk, and it is generally advised against during pregnancy unless absolutely necessary for pathological causes of edema. Patients with obstruction of the urinary tract (e.g., prostatic hypertrophy) require careful monitoring due to the risk of acute urinary retention. Older adults should start with a lower dose and be closely monitored, as they are particularly susceptible to dehydration and electrolyte imbalance. Patients with diabetes, gout, or low blood protein levels (hypoproteinemia) also require special medical caution.

What should I know about interactions with other medicines?

Lasilix Faible (furosemide) can interact with many other medicines, often by increasing the risk of toxicity or severely altering fluid and electrolyte balance. Because of the potential for severe adverse effects, some combinations must be avoided or require very close medical supervision.

Major Interactions and Precautions

Interacting Product Category	Potential Effect	Recommendation/Constraint
Aminoglycoside Antibiotics (e.g., gentamicin)	Significantly increased risk of irreversible inner ear damage (ototoxicity) and kidney damage (nephrotoxicity).	Avoid combination except in life-threatening situations due to the severity of risks.
Lithium (for bipolar disorder)	Reduced clearance of lithium by the kidneys, leading to dangerously high lithium levels and toxicity.	Avoid concomitant use.
ACE Inhibitors/ARBs (e.g., lisinopril, losartan)	Risk of severe, sudden drop in blood pressure (hypotension) and potential deterioration of kidney function, especially when starting treatment.	Close monitoring of blood pressure and kidney function is essential. Dosage adjustment may be required.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)	May reduce the therapeutic effect of Lasilix Faible and increase the risk of kidney problems.	Monitor blood pressure and kidney function closely.
Corticosteroids or Laxatives (prolonged use)	Increased risk of low blood potassium levels (hypokalemia).	Close monitoring of electrolyte levels is necessary.
Sucralfate	May reduce the diuretic effect of Lasilix Faible.	Separate the time of administration by at least two hours.

Other drugs that may interact, requiring caution and monitoring, include the immunosuppressant cyclosporine (risk of gout), thyroid hormones (potential effect on hormone levels), and other drugs that can cause fluid loss or electrolyte imbalance.

Mechanism of Action

Lasilix Faible contains furosemide, a pharmacologic agent whose primary biological target is the sodium-potassium-chloride cotransporter 2 (NKCC2), encoded by the SLC12A1 gene. This transporter is selectively localized to the apical membrane of epithelial cells in the thick ascending limb (TAL) of the loop of Henle within the renal nephron. .

Furosemide acts as a non-competitive inhibitor of NKCC2, binding at the chloride-binding site. This molecular interaction prevents the coupled transport and reabsorption of one sodium ion ( Na^+), one potassium ion ( K^+), and two chloride ions ( Cl^-) from the tubular lumen into the renal cells. The resultant increase in the luminal concentrations of these solutes, particularly Na^+and Cl^-, disrupts the corticomedullary osmotic gradient typically maintained by the TAL.

This downstream cascade results in a diminished osmotic driving force for water reabsorption in the collecting duct. The systemic-level physiological consequence is a substantial modulation of renal function characterized by marked natriuresis (increased sodium excretion) and diuresis (increased water excretion), resulting in a net reduction of extracellular fluid volume.

Dosage and Administration Information

How to Use Lasilix Faible

Lasilix Faible contains the active ingredient furosemide, and its use is strictly guided by specific, non-advisory instructions detailed in approved product labeling. These instructions define the approved method, dosage ranges, and administration timing.

Official Administration Guidelines

Instruction Entity	Regulatory Principle
Route of Administration	The primary route is Oral (tablet, relevant to Lasilix Faible). The drug is also approved for Intravenous and Intramuscular injection in specific clinical settings.
Dosing Schedule	Dosing begins with a low initial oral dose, typically ranging from 20 mg to 80 mg as a single administration or divided over the day. The dose is then titrated to the minimum effective amount necessary for maintenance.
Frequency and Timing	The drug may be taken once daily or in divided doses. Administration should be timed to control the diuresis period and generally avoids evening or nighttime use.
Contextual Intake Rules	Tablets may be taken with or without food. Administration must be separated from certain medications, such as sucralfate, by at least two hours to ensure proper absorption.
Population Rules	Older adults are generally started at the lowest end of the dosing range initially. Pediatric doses are calculated based on body weight (e.g., initial 2 mg/kg dose).

Procedural Structure

The official protocol requires starting with a low, conservative dose and carefully titrating it based on the individual response to achieve the minimal effective therapeutic level. This procedural structure ensures that the administration method, frequency, and timing align with the specific instructions found in approved labeling.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Lasilix Faible (Furosemide 20 mg)

Evidence for use in Fluid Retention (Edema) due to Heart Problems

This section will summarize studies, including different types of clinical trials, that have evaluated research exploring Lasilix Faible in the context of excess fluid buildup related to heart conditions.

Research has examined Lasilix Faible (furosemide 20 mg) in people experiencing fluid retention as a result of heart problems, which is a condition characterized by fluctuating or episodic manifestations of swelling, primarily in the legs and abdomen. The studies monitored changes related to fluid retention, such as changes in the body's excess fluid.

Findings from various research settings suggest patterns related to fluid retention observed in the studies. For example, some studies report how symptoms evolved in the observed populations during periods of short-term use. The medication was studied in research contexts involving fluid retention, and research highlights changes measured during the study period related to swelling and outcomes reflecting daily functioning or activity level.

Evidence for use in Fluid Retention (Edema) due to Kidney or Liver Problems

This section will present an overview of the research exploring Lasilix Faible in relation to excess fluid retention resulting from different types of kidney and liver diseases.

Research describes how the medication was evaluated in settings involving excess fluid and salts when the kidneys or liver are not functioning optimally.

The clinical trials and studies in these populations focused on research exploring short-term symptom changes and outcomes related to physical discomfort associated with fluid retention. Data show patterns related to symptom intensity and variability in these conditions. Findings help contextualize how patients reported their experience of fluid retention during the study period.

Long-term Studies and Follow-up for Lasilix Faible

Research has explored the patterns of use of Lasilix Faible in long-term observational settings evaluating daily-life functioning. These studies focus on the ongoing pattern of symptom management over months or even years. They look at patterns of response over time and patient-reported outcomes describing perceived discomfort associated with long-term conditions.

Overall, research indicates long-term effects are not fully established, as data show follow-up durations were limited in many of the key studies. This means that evidence suggests there is limited information for long-term outcomes that come directly from research settings.

What is Still Uncertain about Lasilix Faible

One main gap is the lack of head-to-head comparative research. Comparative evidence is lacking to definitively establish the relative role of the 20 mg dose versus higher doses or against other types of fluid-managing medications.

Further research is needed in understanding long-term consequences, assessing the medication in different ethnic or genetic subgroups, and clarifying its role in very specific, rare disease manifestations where data are still emerging. Studies help show what has been observed so far, but more work is required to fill these knowledge gaps.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Lasilix Faible (FAQ)

Q: How quickly does Lasilix Faible start to work after taking it?

According to the official product information, the diuretic effect—meaning the increased urge to pass water—typically begins relatively quickly. This effect usually starts within one hour after taking the tablet.

Q: How long does the effect of Lasilix Faible typically last?

Official documents state that the duration of the diuretic effect for the oral tablet is generally between 6 to 8 hours.

Q: Do I need a prescription to get Lasilix Faible?

Lasilix Faible is classified as a prescription-only medicine. This is implied by regulatory guidance, which requires the drug to be prescribed by a healthcare provider and specifies that dosages are determined individually.

Q: Are there any known issues with drinking alcohol while using Lasilix Faible?

Official information describes that limiting alcohol consumption is advised while using this medicine. This is because alcohol can increase the risk of dehydration or an unwanted drop in blood pressure when combined with the drug's effects.

Q: What are the most commonly reported side effects mentioned in official patient leaflets?

Official regulatory documents list several commonly reported side effects. These include frequent urination, as well as general effects like headache, dizziness, diarrhea, constipation, numbness or tingling, and blurred vision.

Q: Is there a link between Lasilix Faible and sun sensitivity?

Official product information mentions photosensitivity as a possible adverse reaction. This means there is an increased sensitivity to sunlight. This condition is described in the official label information.

Q: What happens if I miss a scheduled amount of the medicine?

Regulatory guidance describes the procedure for a missed dose. These instructions typically state that if a dose is missed, it can be taken when remembered, unless it is close to the next scheduled time, in which case the missed dose is skipped. It is specified that taking double doses is not advised.

Q: Can Lasilix Faible affect the results of certain medical tests?

Official warnings indicate that laboratory staff and physicians must be informed that the drug is being taken before specific procedures. This is important before having a glucose test or certain X-rays or scans that involve the use of iodine dye.

Q: What official warnings exist about using Lasilix Faible during pregnancy or while breastfeeding?

Official warnings state that use during pregnancy is generally not recommended unless the benefit to the mother outweighs the potential risk to the fetus, and close monitoring is required. For breastfeeding, the drug is excreted into human milk, and caution is advised because high doses might potentially decrease lactation.

Q: Are there restrictions on driving or operating machinery while taking this medicine?

Regulatory sources state that the drug may affect alertness or coordination. Official product information states that because the drug may affect these functions, caution regarding driving or operating heavy machinery is necessary if the patient experiences effects like dizziness.

Q: Can I take Lasilix Faible if I am taking medicines for diabetes?

Official information notes that Lasilix Faible may diminish the effectiveness of insulin and other anti-diabetic medications by raising blood sugar levels. Regulatory information states that increased blood glucose monitoring may be necessary when this medication is taken alongside diabetes treatment.

Q: What medical conditions are listed as reasons why someone should not use Lasilix Faible?

The drug is generally contraindicated, meaning it should not be used, if a patient has a known allergy to furosemide or similar drugs (sulfonamides). It is also contraindicated in individuals who are unable to pass urine (anuria) or have very low levels of body salts (electrolytes).

Q: Does Lasilix Faible have any known interactions with herbal supplements?

Official information states that a physician must be informed about all herbal products and supplements a patient is currently using. This is necessary because of the need to monitor for potential, unlisted interactions that could affect safety or effectiveness.

Q: Why is it important to stay hydrated while taking a diuretic?

Regulatory information warns that the medication causes water loss, which carries a risk of dehydration. Official guidance states that supportive measures to maintain adequate hydration may be necessary, particularly in cases of increased sweating, vomiting, or diarrhea.

Q: How are the storage conditions for Lasilix Faible described in the official leaflet?

Official storage instructions state that the medicine should be kept at a controlled room temperature, typically 20°C to 25°C. The product must also be protected from light to maintain its effectiveness.

Q: Do any official warnings exist about taking Lasilix Faible before surgery?

Official warnings indicate that the doctor must be informed that the drug is being taken before any major operation or receiving a general anesthetic. This is an important safety step related to managing fluid balance during procedures.

Q: Are there specific instructions for what to do if an allergic reaction is suspected?

Official guidance states that if signs of a severe reaction occur, the drug must be discontinued and emergency medical attention is required immediately.

How should Lasilix Faible be stored and disposed of?

Storage and Disposal Requirements

Lasilix Faible (furosemide 20 mg tablets) must be stored at Controlled Room Temperature, defined as 25 C (77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F). The product must be Protected From Light and Protected From Moisture and kept in a tight, light-resistant container.

Exposure to light may cause slight discoloration of the tablets; any discolored tablets must not be dispensed. Like all medicines, the product must be stored out of the reach of children.

Disposal of unused or expired medicine must follow local regulatory requirements and should not be discarded via wastewater or household waste.

Lasilix Faible